Ionis Announces FDA Approval of ZANVASTRO for Alexander Disease
The FDA has approved Ionis Pharmaceuticals' ZANVASTRO, the first disease-modifying therapy for Alexander disease. This approval marks Ionis' second independent launch of the year and includes a Priority Review Voucher.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day